Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr
Arco Lab now holds a 50% stake in Neviton
Arco Lab now holds a 50% stake in Neviton
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The deal includes upfront payments, milestone payments and ongoing royalties
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The company has received five final approvals
The company received gross proceeds of approximately US$1.7 million and net proceeds,
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Subscribe To Our Newsletter & Stay Updated